U.S. FDA Funds 'Coronaviruses' Study

The U.S. FDA announced on September 14, 2020, that is has awarded a new research contract to sequence and analyze samples from humans and animals to create profiles of various coronaviruses.

In this Medical Countermeasures Initiative regulatory science project, the University of Liverpool, and international partners will analyze SARS-CoV-2, SARS-CoV, and MERS-CoV clinical samples.

This regulatory science project, awarded in collaboration with the National Institutes of Health, National Institute of Allergy and Infectious Diseases, will hopefully help inform the development and evaluation of medical countermeasures for COVID-19, which is caused by the new coronavirus.